Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2010 (2010), Article ID 686734, 10 pages
http://dx.doi.org/10.1155/2010/686734
Research Article

Peripheral 5-HT 1A and 5-HT 7 Serotonergic Receptors Modulate Parasympathetic Neurotransmission in Long-Term Diabetic Rats

1Laboratorio de Farmacología, Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain
2Grupo de Enfermedades Cardiovasculares y Metabólicas, Facultad de Ciencias de la Salud, Universidad del Quindío, Carrera 15, Calle 12N, Armenia, Quindío, Colombia

Received 13 September 2010; Revised 18 November 2010; Accepted 26 December 2010

Academic Editor: Mark A. Yorek

Copyright © 2010 Beatriz Restrepo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. Ramage and C. M. Villalón, “5-hydroxytryptamine and cardiovascular regulation.,” Trends in Pharmacological Sciences, vol. 29, no. 9, pp. 472–481, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. W. Ni, T. J. Geddes, J. R. C. Priestley, T. Szasz, D. M. Kuhn, and S. W. Watts, “The existence of a local 5-hydroxytryptaminergic system in peripheral arteries,” British Journal of Pharmacology, vol. 154, no. 3, pp. 663–674, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. Y. Wang, A. G. Ramage, and D. Jordan, “Presynaptic 5-HT3 receptors evoke an excitatory response in dorsal vagal preganglionic neurones in anaesthetized rats,” Journal of Physiology, vol. 509, no. 3, pp. 683–694, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Tonini, C. A. Rizzi, L. Manzo, and L. Onori, “Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action,” Pharmacological Research, vol. 24, no. 1, pp. 5–14, 1991. View at Google Scholar · View at Scopus
  5. S. C. E. Sporton, S. L. Shepheard, D. Jordan, and A. G. Ramage, “Microinjections of 5-HT1A agonists into the dorsal motor vagal nucleus produce a bradycardia in the atenolol-pretreated anaesthetized rat,” British Journal of Pharmacology, vol. 104, no. 2, pp. 466–470, 1991. View at Google Scholar · View at Scopus
  6. S. L. Shepheard, D. Jordan, and A. G. Ramage, “Comparison of the effects of IVth ventricular administration of some tryptamine analogues with those of 8-OH-DPAT on autonomic outflow in the anaesthetized cat,” British Journal of Pharmacology, vol. 111, no. 2, pp. 616–624, 1994. View at Google Scholar · View at Scopus
  7. M. R. Skinner, A. G. Ramage, and D. Jordan, “Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits,” British Journal of Pharmacology, vol. 137, no. 6, pp. 861–873, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. O. Kellett, A. G. Ramage, and D. Jordan, “Central 5-HT7 receptors are critical for reflex activation of cardiac vagal drive in anaesthetized rats,” Journal of Physiology, vol. 563, no. 1, pp. 319–331, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. M. Villalón and D. Centurión, “Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 376, no. 1-2, pp. 45–63, 2007. View at Google Scholar · View at Scopus
  10. M. Tonini, T. Coccini, L. Onori, S. M. Candura, C. A. Rizzi, and L. Manzo, “The influence of neuronal 5-hydroxytryptamine receptor antagonists on non-cholinergic ganglionic transmission in the guinea-pig enteric excitatory reflex,” British Journal of Pharmacology, vol. 107, no. 1, pp. 5–7, 1992. View at Google Scholar · View at Scopus
  11. A. Moran, C. Velasco, M. L. Martin, and L. S. Roman, “Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart,” European Journal of Pharmacology, vol. 252, no. 2, pp. 161–166, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. M. García, A. Morán, M. L. Martín, A. V. Ortiz de Urbina, and L. San Román, “Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally induced bradycardia in rat heart,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 11, pp. 1199–1206, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. H. J. Park, Y. Zhang, C. Du et al., “Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic akita mice,” Circulation Research, vol. 105, no. 3, pp. 287–294, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. G. McLeod, “Autonomic dysfunction in peripheral nerve disorders,” Current Opinion in Neurology and Neurosurgery, vol. 5, no. 4, pp. 476–481, 1992. View at Google Scholar · View at Scopus
  15. T. S. McDowell, M. W. Chapleau, G. Hajduczok, and F. M. Abboud, “Baroreflex dysfunction in diabetes mellitus. I. Selective impairment of parasympathetic control of heart rate,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 266, no. 1, pp. H235–H243, 1994. View at Google Scholar · View at Scopus
  16. K. E. Belmonte, D. B. Jacoby, and A. D. Fryer, “Increased function of inhibitory neuronal M muscarinic receptors in diabetic rat lungs,” British Journal of Pharmacology, vol. 121, no. 7, pp. 1287–1294, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. A. Alabadí, F. J. Miranda, S. Lloréns, R. F. Ruiz de Apodaca, J. M. Centeno, and E. Alborch, “Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries,” European Journal of Pharmacology, vol. 415, no. 2-3, pp. 225–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. F. R. Coulson, D. B. Jacoby, and A. D. Fryer, “Increased function of inhibitory neuronal M2 muscarinic receptors in trachea and ileum of diabetic rats,” British Journal of Pharmacology, vol. 135, no. 6, pp. 1355–1362, 2002. View at Google Scholar · View at Scopus
  19. M. Lishner, S. Akselrod, V. Mor Avi, O. Oz, M. Divon, and M. Ravid, “Spectral analysis of heart rate fluctuations. A non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus,” Journal of the Autonomic Nervous System, vol. 19, no. 2, pp. 119–125, 1987. View at Google Scholar
  20. J. S. Gillespie and T. C. Muir, “A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat,” British Journal of Pharmacology, vol. 30, no. 1, pp. 78–87, 1967. View at Google Scholar · View at Scopus
  21. D. K. Agrawal, S. Bhimji, and J. H. McNeill, “Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery,” Journal of Cardiovascular Pharmacology, vol. 9, no. 5, pp. 584–593, 1987. View at Google Scholar · View at Scopus
  22. Y. Öztürk, V. M. Altan, and N. Yildizoǧlu-Ari, “Effects of experimental diabetes and insulin on smooth muscle functions,” Pharmacological Reviews, vol. 48, no. 1, pp. 69–112, 1996. View at Google Scholar · View at Scopus
  23. N. N. Chan, P. Vallance, and H. M. Colhoun, “Nitric oxide and vascular responses in Type I diabetes,” Diabetologia, vol. 43, no. 2, pp. 137–147, 2000. View at Google Scholar · View at Scopus
  24. F. J. Miranda, J. A. Alabadí, S. Lloréns, R. F. Ruiz de Apodaca, J. M. Centeno, and E. Alborch, “Experimental diabetes induces hyperreactivity of rabbit renal artery to 5-hydroxytryptamine,” European Journal of Pharmacology, vol. 439, no. 1–3, pp. 121–127, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. H. Lee, M. Konarska, and R. McCarty, “Physiological responses to acute stress in alloxan and streptozotocin diabetic rats,” Physiology and Behavior, vol. 45, no. 3, pp. 483–489, 1989. View at Google Scholar · View at Scopus
  26. B. E. Zola, B. Miller, G. L. Stiles, P. S. Rao, E. H. Sonnenblick, and F. S. Fein, “Heart rate control in diabetic rabbits: blunted response to isoproterenol,” American Journal of Physiology—Endocrinology and Metabolism, vol. 255, no. 5, pp. E636–E641, 1988. View at Google Scholar
  27. F. C. Howarth, M. Jacobson, M. Shafiullah, M. Ljubisavljevic, and E. Adeghate, “Heart rate, body temperature and physical activity are variously affected during insulin treatment in alloxan-induced type 1 diabetic rat,” Physiological Research. In press.
  28. N. Akiyama, K. Okumura, Y. Watanabe et al., “Altered acethlcholine and norepinephrine concentrations in diabetic rat hearts. Role of parasympathetic nervous system in diabetic cardiomyopathy,” Diabetes, vol. 38, no. 2, pp. 231–236, 1989. View at Google Scholar · View at Scopus
  29. P. Lo Giudice, A. Careddu, G. Magni, T. Quagliata, L. Pacifici, and P. Carminati, “Autonomic neuropathy in streptozotocin diabetic rats: effect of acetyl-L-carnitine,” Diabetes Research and Clinical Practice, vol. 56, no. 3, pp. 173–180, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Martinez-Nieves, H. L. Collins, and S. E. DiCarlo, “Autonomic and endothelial dysfunction in experimental diabetes,” Clinical and Experimental Hypertension, vol. 22, no. 6, pp. 623–634, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Ago, S. Nakamura, N. Kajita et al., “Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice,” Synapse, vol. 61, no. 9, pp. 757–763, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. K. C. Tomlinson, S. M. Gardiner, R. A. Hebden, and T. Bennett, “Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system,” Pharmacological Reviews, vol. 44, no. 1, pp. 103–150, 1992. View at Google Scholar · View at Scopus
  33. D. R. Tomlinson and A. P. M. Yusof, “Autonomic neuropathy in the alloxan-diabetic rat,” Journal of Autonomic Pharmacology, vol. 3, no. 4, pp. 257–263, 1983. View at Google Scholar · View at Scopus
  34. J. Roquebert, A. Moran, P. Demichel, and M. F. Sauvage, “Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart,” European Journal of Pharmacology, vol. 200, no. 1, pp. 59–63, 1991. View at Google Scholar · View at Scopus
  35. N. Yonehara, K. Saito, S. Uchida, Y. Noguchi, and H. Yoshida, “Effects of muscarinic agonists and antagonists on the negative chronotropic responses to the vagus nerve stimulation,” Japanese Journal of Pharmacology, vol. 29, no. 5, pp. 797–799, 1979. View at Google Scholar
  36. P. Fuchs and H. Fuder, “The determination of presynaptic K(A) values of methacholine and pilocarpine and of a presynaptic receptor reserve in the rat perfused heart,” British Journal of Pharmacology, vol. 84, no. 1, pp. 35–46, 1985. View at Google Scholar · View at Scopus
  37. G. T. Wetzel and J. H. Brown, “Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons,” American Journal of Physiology, vol. 248, no. 1, pp. H33–H39, 1985. View at Google Scholar · View at Scopus
  38. Y. C. Tong, J. T. Cheng, and W. C. Wan, “Effects of Ba-Wei-Die-Huang-Wan on the cholinergic function and protein expression of M muscarinic receptor of the urinary bladder in diabetic rats,” Neuroscience Letters, vol. 330, no. 1, pp. 21–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Oberhauser, E. Schwertfeger, T. Rutz, F. Beyersdorf, and L. C. Rump, “Acetylcholine release in human heart atrium influence of muscarinic autoreceptors, diabetes, and age,” Circulation, vol. 103, no. 12, pp. 1638–1643, 2001. View at Google Scholar · View at Scopus
  40. D. Hoyer, D. E. Clarke, J. R. Fozard et al., “International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin),” Pharmacological Reviews, vol. 46, no. 2, pp. 157–203, 1994. View at Google Scholar · View at Scopus
  41. G. Baxter, G. Kennett, F. Blaney, and T. Blackburn, “5-HT2 receptor subtypes: a family re-united?” Trends in Pharmacological Sciences, vol. 16, no. 3, pp. 105–110, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. S. J. Ireland and M. B. Tyers, “Pharmacological characterization of 5-hydroxyltryptamine-induced depolarization of the rat isolated vagus nerve,” British Journal of Pharmacology, vol. 90, no. 1, pp. 229–238, 1987. View at Google Scholar · View at Scopus
  43. J. Chen, H. M. van Praag, and E. L. Gardner, “Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens,” Brain Research, vol. 543, no. 2, pp. 354–357, 1991. View at Publisher · View at Google Scholar · View at Scopus
  44. S. B. Dando, M. R. Skinner, D. Jordan, and A. G. Ramage, “Modulation of the vagal bradycardia evoked by stimulation of upper airway receptors by central 5-HT1 receptors in anaesthetized rabbits,” British Journal of Pharmacology, vol. 125, no. 2, pp. 409–417, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. D. N. Middlemiss and J. R. Fozard, “8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site,” European Journal of Pharmacology, vol. 90, no. 1, pp. 151–153, 1983. View at Google Scholar · View at Scopus
  46. M. S. Beer, J. A. Stanton, Y. Bevan et al., “L-694,247: a potent 5-HT(1D) receptor agonist,” British Journal of Pharmacology, vol. 110, no. 3, pp. 1196–1200, 1993. View at Google Scholar · View at Scopus
  47. D. M. Tomkins and M. F. O'Neill, “Effect of 5-HT1B receptor ligands on self-administration of ethanol in an operant procedure in rats,” Pharmacology Biochemistry and Behavior, vol. 66, no. 1, pp. 129–136, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. E. A. Forster, I. A. Cliffed, D. J. Bill et al., “A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635,” European Journal of Pharmacology, vol. 281, no. 1, pp. 81–88, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. B. L. Roth, S. C. Craigo, M. S. Choudhary et al., “Binding of typical and atypical antipsychotic agents to 5- hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors,” Journal of Pharmacology and Experimental Therapeutics, vol. 268, no. 3, pp. 1403–1410, 1994. View at Google Scholar · View at Scopus
  50. D. Centurion, A. Sanchez-Lopez, M. I. Ortiz, P. de Vries, P. R. Saxena, and C. M. Villalon, “Mediation of 5-HT-induced internal carotid vasodilatation in GR127935- and ritanserin-pretreated dogs by 5-HT7 receptors,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 362, no. 2, pp. 169–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. M. J. Ramírez, E. Cenarruzabeitia, B. Lasheras, and J. del Rio, “5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices,” Brain Research, vol. 757, no. 1, pp. 17–23, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Mostany, A. Pazos, and M. E. Castro, “Autoradiographic characterisation of [S]GTPγS binding stimulation mediated by 5-HT1B receptor in postmortem human brain,” Neuropharmacology, vol. 48, no. 1, pp. 25–33, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. G. H. Dreteler, W. Wouters, and P. R. Saxena, “Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat,” European Journal of Pharmacology, vol. 180, no. 2-3, pp. 339–349, 1990. View at Publisher · View at Google Scholar · View at Scopus
  54. S. P. H. Alexander, A. Mathie, and J. A. Peters, “Guide to Receptors and Channels (GRAC), 3rd edition,” British Journal of Pharmacology, vol. 153, no. 2, pp. S1–S196, 2008. View at Publisher · View at Google Scholar · View at PubMed
  55. D. Oskutyte, D. Jordant, and A. G. Ramage, “Evidence that 5-hydroxytryptamine7 receptors play a role in the mediation of afferent transmission within the nucleus tractus solitarius in anaesthetized rats,” British Journal of Pharmacology, vol. 158, no. 5, pp. 1387–1394, 2009. View at Publisher · View at Google Scholar · View at PubMed